RADIENT PHARMACEUTICALS CORPORATION

Company News Products Distribution Resources Investor Contact

 

Safe Harbor Stmt
New Business Focus
Board of Directors
Corporate Presentation
Code of Ethics
Management Team
China Pharma
Return Home

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this website include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company’s operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Inc., except for the historical information contained herein, the matters discussed in this website are forward looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. There may be potential risks and uncertainties related to the Company’s access to additional capital, competition and dependence on key management.